These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32785089)

  • 1. The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.
    Moscoso CG; Steer CJ
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32785089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver targeted gene therapy: Insights into emerging therapies.
    Moscoso CG; Steer CJ
    Drug Discov Today Technol; 2019 Dec; 34():9-19. PubMed ID: 33357766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic-Based Approaches to Inherited Metabolic Liver Diseases.
    Zabaleta N; Hommel M; Salas D; Gonzalez-Aseguinolaza G
    Hum Gene Ther; 2019 Oct; 30(10):1190-1203. PubMed ID: 31347416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel vectors and approaches for gene therapy in liver diseases.
    Maestro S; Weber ND; Zabaleta N; Aldabe R; Gonzalez-Aseguinolaza G
    JHEP Rep; 2021 Aug; 3(4):100300. PubMed ID: 34159305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral Vectors for Cancer Gene Therapy.
    Schambach A; Morgan M
    Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapies targeting the liver.
    Cozmescu AC; Counsell J; Gissen P
    J Hepatol; 2021 Jan; 74(1):235-236. PubMed ID: 33071009
    [No Abstract]   [Full Text] [Related]  

  • 11. Current Status on Clinical Development of Adeno-Associated Virus-Mediated Liver-Directed Gene Therapy for Inborn Errors of Metabolism.
    Ginocchio VM; Ferla R; Auricchio A; Brunetti-Pierri N
    Hum Gene Ther; 2019 Oct; 30(10):1204-1210. PubMed ID: 31517544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-editing Technologies for Gene and Cell Therapy.
    Maeder ML; Gersbach CA
    Mol Ther; 2016 Mar; 24(3):430-46. PubMed ID: 26755333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome engineering: a new approach to gene therapy for neuromuscular disorders.
    Nelson CE; Robinson-Hamm JN; Gersbach CA
    Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.
    Bryson TE; Anglin CM; Bridges PH; Cottle RN
    Yale J Biol Med; 2017 Dec; 90(4):553-566. PubMed ID: 29259521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing in liver diseases.
    Torella L; Santana-Gonzalez N; Zabaleta N; Gonzalez Aseguinolaza G
    FEBS Lett; 2024 Oct; 598(19):2348-2371. PubMed ID: 39079936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
    Farooq R; Hussain K; Tariq M; Farooq A; Mustafa M
    J Appl Genet; 2020 Feb; 61(1):51-65. PubMed ID: 31912450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy and Genome Editing.
    Boulad F; Mansilla-Soto J; Cabriolu A; Rivière I; Sadelain M
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):329-342. PubMed ID: 29458735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
    Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
    Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods.
    Palaschak B; Herzog RW; Markusic DM
    Methods Mol Biol; 2019; 1950():333-360. PubMed ID: 30783984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.